Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shilin Xu

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Sensors (Basel, Switzerland)|December 2, 2020
Computation Offloading in a Cognitive Vehicular Networks with Vehicular Cloud Computing and Remote Cloud ComputingShilin Xu, Caili Guo
Frontiers in Psychology|September 19, 2022
Impact of Efficient Resource Management Practices on Sustainable Performance: Moderating Role of Innovative Culture-Evidence From Oil and Gas FirmsYihan Wang, Shaojie Zhang, Shilin Xu
Journal of Medicinal Chemistry|October 12, 2019
Tyrosine Kinase 2 (TYK2) Allosteric Inhibitors To Treat Autoimmune DiseasesYu Chang, Shilin Xu, Ke Ding
Future Medicinal Chemistry|August 21, 2025
Recent advances in small molecules targeting the METTL3Feifei Wu, Lei Yu, Shilin Xu
Frontiers in Neurology|July 29, 2022
Cervical Cancer Imaging Features Associated With <i>ADRB1</i> as a Risk Factor for Cerebral Neurovascular MetastasesXingju Zheng, Shilin Xu, JiaYing Wu
Journal of Neurology|June 1, 2020
Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatmentLumei Kang, Yuyang Tian, Shilin Xu, et al.
Expert Opinion on Therapeutic Patents|January 8, 2026
A patent review of KDM4 histone demethylase inhibitors (2014-present)Xiaolong Yang, Yuyan Han, Lei Yu, et al.
Developmental Science|December 19, 2025
Abnormal Developmental Trajectories in the Brain in Individuals With Reading Disability: Developmental changes in reading disabilityXiaohui Yan, Shilin Xu, Guoyan Feng, et al.
Hematology (Amsterdam, Netherlands)|February 4, 2021
HOTAIR suppresses PTEN via DNMT3b and confers drug resistance in acute myeloid leukemiaWei Zhou, Shilin Xu, Xiaowei Chen, et al.
Human Cell|October 25, 2021
LncRNA USP30-AS1 promotes the survival of acute myeloid leukemia cells by cis-regulating USP30 and ANKRD13AWei Zhou, Shilin Xu, Tingfen Deng, et al.
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Sensors (Basel, Switzerland)|December 2, 2020
Computation Offloading in a Cognitive Vehicular Networks with Vehicular Cloud Computing and Remote Cloud ComputingShilin Xu, Caili Guo
Frontiers in Psychology|September 19, 2022
Impact of Efficient Resource Management Practices on Sustainable Performance: Moderating Role of Innovative Culture-Evidence From Oil and Gas FirmsYihan Wang, Shaojie Zhang, Shilin Xu
Journal of Medicinal Chemistry|October 12, 2019
Tyrosine Kinase 2 (TYK2) Allosteric Inhibitors To Treat Autoimmune DiseasesYu Chang, Shilin Xu, Ke Ding
Future Medicinal Chemistry|August 21, 2025
Recent advances in small molecules targeting the METTL3Feifei Wu, Lei Yu, Shilin Xu
Frontiers in Neurology|July 29, 2022
Cervical Cancer Imaging Features Associated With <i>ADRB1</i> as a Risk Factor for Cerebral Neurovascular MetastasesXingju Zheng, Shilin Xu, JiaYing Wu
Journal of Neurology|June 1, 2020
Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatmentLumei Kang, Yuyang Tian, Shilin Xu, et al.
Expert Opinion on Therapeutic Patents|January 8, 2026
A patent review of KDM4 histone demethylase inhibitors (2014-present)Xiaolong Yang, Yuyan Han, Lei Yu, et al.
Developmental Science|December 19, 2025
Abnormal Developmental Trajectories in the Brain in Individuals With Reading Disability: Developmental changes in reading disabilityXiaohui Yan, Shilin Xu, Guoyan Feng, et al.
Hematology (Amsterdam, Netherlands)|February 4, 2021
HOTAIR suppresses PTEN via DNMT3b and confers drug resistance in acute myeloid leukemiaWei Zhou, Shilin Xu, Xiaowei Chen, et al.
Human Cell|October 25, 2021
LncRNA USP30-AS1 promotes the survival of acute myeloid leukemia cells by cis-regulating USP30 and ANKRD13AWei Zhou, Shilin Xu, Tingfen Deng, et al.
Pageof 13